Top View
- Final1-Aritmo-Final-Report-V2-0Final.Pdf
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- Bedaquiline: 10 Years Later, the Drug Susceptibility Testing Protocol Is Still Pending
- Mechanisms of Drug Resistance in Mycobacterium Tuberculosis: Update 2015
- Host-Directed Therapeutics As a Novel Approach for Tuberculosis Treatment Ye-Ram Kim1,2 and Chul-Su Yang1,2*
- Regimen for Multidrug-Resistant Tuberculosis in Brazil, 2000–2015
- Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
- Tuberculosis Epidemiology, Pathogenesis, Drugs and Drug Resistance Development: a Review Bedaso Kebede1,2*
- Guidelines for Drug Susceptibility Testing for Second-Line Anti-Tuberculosis Drugs for Dots-Plus
- Public Assessment Report
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- SIRTURO Safely and Effectively
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Pharmacokinetic Study of Anti-Tb Drug Para-Aminosalicylic Acid and Its Metabolites: a Possible Relationship with the Development of Toxicity
- Pharmacokinetics and Dosing Rationale of Para
- Effectiveness and Safety of Clofazimine In€Multidrug-Resistant Tuberculosis
- Deciphering Antimycobacterial Activity of Cyclophostin/Cyclipostins
- Australian Statistics on Medicines 2009
- 212862Orig1s000 OTHER REVIEW(S)
- Antituberculotic Chemotherapy-General and Hepatic Toxicity Revisited
- Lack of Evidence to Support Policy Development for Management of Contacts of Multidrug-Resistant Tuberculosis Patients: Two Systematic Reviews
- Annual Report 2018 Tuberculosis & Chest
- Report on the Deliberation Results May 16, 2014 Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministr
- University of Cape Town
- (12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
- Discovery, Characterization and Structural Studies of Inhibitors Against Mycobacterium Tuberculosis Adenosine Kinase and Biotin
- An Activist's Guide to Tuberculosis Drugs 2016 Update
- Terizidone J04ak03
- Bedaquiline in MDR/XDR-TB Cases: First Experience on Compassionate Use
- Critically Important Antimicrobials for Human Medicine, 6Th Revision
- Supplementary Materials for Table of Contents PICO Questions
- Open Research Online Oro.Open.Ac.Uk
- 204384Orig1s000
- View and Official Information Passed on by the Ministry of Health and International Bodies, Are
- SIRTURO (Bedaquiline) Label
- WHO List of Critically Important Anti-‐Microbials, 2011 Rev 3
- The Use of Bedaquiline in the Treatment of Multidrug Resistant Tuberculosis
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- Adverse Drug Reactions in South African Patients Receiving
- Critically Important Antimicrobials for Human Medicine
- ARPEC Protocol for Drug Utilization Study
- New Drugs for the Treatment of Tuberculosis
- Management of Rifampicin- Resistant Tuberculosis
- First Case of Extensively Drug-Resistant Tuberculosis Treated with Both Delamanid and Bedaquiline
- Data Sheet of Clinical Trial C.T
- Second-Line Antituberculosis Drugs in Children